2,3,4,5-tetrahydropyridin-6-amine and 3,4-dihydro-2H-pyrrol-5-amine compound inhibitors of beta-secretase

wherein the radicals are as defined in the specification. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention and treatment of disorde...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Van Brandt, Sven Franciscus Anna, De Cleyn, Michel Anna Jozef, Delgado-González, Óscar, Mateu Sanchís, Natalia, Gijsen, Henricus Jacobus Maria, Fustero Lardiés, Santos, Van Gool, Michiel Luc Maria, Trabanco-Suárez, Andrés Avelino
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Van Brandt, Sven Franciscus Anna
De Cleyn, Michel Anna Jozef
Delgado-González, Óscar
Mateu Sanchís, Natalia
Gijsen, Henricus Jacobus Maria
Fustero Lardiés, Santos
Van Gool, Michiel Luc Maria
Trabanco-Suárez, Andrés Avelino
description wherein the radicals are as defined in the specification. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention and treatment of disorders in which beta-secretase is involved, such as Alzheimer's disease (AD), mild cognitive impairment, senility, dementia, dementia with Lewy bodies, Down's syndrome, dementia associated with stroke, dementia associated with Parkinson's disease, dementia associated with beta-amyloid, age-related macular degeneration, type 2 diabetes or metabolic disorders.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US10106524B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US10106524B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US10106524B23</originalsourceid><addsrcrecordid>eNqNyjEOgjAUgGEWB6Peoey8BArlABoNuzqTQh_hJdDXtHXg9jaGAzj9w_8dM5JFXTSFgojR63kznt3myZCFFvRKFoW2RiQDhn4bZAeJeF5A7WLk1fEnMbIzDRTZB8GTGDBqCDj61IDn7DDpJeBl7ynLH_fXrQN03GNwekSLsX8_q7IqWyWbq6z_MV-_VT6A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>2,3,4,5-tetrahydropyridin-6-amine and 3,4-dihydro-2H-pyrrol-5-amine compound inhibitors of beta-secretase</title><source>esp@cenet</source><creator>Van Brandt, Sven Franciscus Anna ; De Cleyn, Michel Anna Jozef ; Delgado-González, Óscar ; Mateu Sanchís, Natalia ; Gijsen, Henricus Jacobus Maria ; Fustero Lardiés, Santos ; Van Gool, Michiel Luc Maria ; Trabanco-Suárez, Andrés Avelino</creator><creatorcontrib>Van Brandt, Sven Franciscus Anna ; De Cleyn, Michel Anna Jozef ; Delgado-González, Óscar ; Mateu Sanchís, Natalia ; Gijsen, Henricus Jacobus Maria ; Fustero Lardiés, Santos ; Van Gool, Michiel Luc Maria ; Trabanco-Suárez, Andrés Avelino</creatorcontrib><description>wherein the radicals are as defined in the specification. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention and treatment of disorders in which beta-secretase is involved, such as Alzheimer's disease (AD), mild cognitive impairment, senility, dementia, dementia with Lewy bodies, Down's syndrome, dementia associated with stroke, dementia associated with Parkinson's disease, dementia associated with beta-amyloid, age-related macular degeneration, type 2 diabetes or metabolic disorders.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20181023&amp;DB=EPODOC&amp;CC=US&amp;NR=10106524B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20181023&amp;DB=EPODOC&amp;CC=US&amp;NR=10106524B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Van Brandt, Sven Franciscus Anna</creatorcontrib><creatorcontrib>De Cleyn, Michel Anna Jozef</creatorcontrib><creatorcontrib>Delgado-González, Óscar</creatorcontrib><creatorcontrib>Mateu Sanchís, Natalia</creatorcontrib><creatorcontrib>Gijsen, Henricus Jacobus Maria</creatorcontrib><creatorcontrib>Fustero Lardiés, Santos</creatorcontrib><creatorcontrib>Van Gool, Michiel Luc Maria</creatorcontrib><creatorcontrib>Trabanco-Suárez, Andrés Avelino</creatorcontrib><title>2,3,4,5-tetrahydropyridin-6-amine and 3,4-dihydro-2H-pyrrol-5-amine compound inhibitors of beta-secretase</title><description>wherein the radicals are as defined in the specification. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention and treatment of disorders in which beta-secretase is involved, such as Alzheimer's disease (AD), mild cognitive impairment, senility, dementia, dementia with Lewy bodies, Down's syndrome, dementia associated with stroke, dementia associated with Parkinson's disease, dementia associated with beta-amyloid, age-related macular degeneration, type 2 diabetes or metabolic disorders.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyjEOgjAUgGEWB6Peoey8BArlABoNuzqTQh_hJdDXtHXg9jaGAzj9w_8dM5JFXTSFgojR63kznt3myZCFFvRKFoW2RiQDhn4bZAeJeF5A7WLk1fEnMbIzDRTZB8GTGDBqCDj61IDn7DDpJeBl7ynLH_fXrQN03GNwekSLsX8_q7IqWyWbq6z_MV-_VT6A</recordid><startdate>20181023</startdate><enddate>20181023</enddate><creator>Van Brandt, Sven Franciscus Anna</creator><creator>De Cleyn, Michel Anna Jozef</creator><creator>Delgado-González, Óscar</creator><creator>Mateu Sanchís, Natalia</creator><creator>Gijsen, Henricus Jacobus Maria</creator><creator>Fustero Lardiés, Santos</creator><creator>Van Gool, Michiel Luc Maria</creator><creator>Trabanco-Suárez, Andrés Avelino</creator><scope>EVB</scope></search><sort><creationdate>20181023</creationdate><title>2,3,4,5-tetrahydropyridin-6-amine and 3,4-dihydro-2H-pyrrol-5-amine compound inhibitors of beta-secretase</title><author>Van Brandt, Sven Franciscus Anna ; De Cleyn, Michel Anna Jozef ; Delgado-González, Óscar ; Mateu Sanchís, Natalia ; Gijsen, Henricus Jacobus Maria ; Fustero Lardiés, Santos ; Van Gool, Michiel Luc Maria ; Trabanco-Suárez, Andrés Avelino</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US10106524B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2018</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Van Brandt, Sven Franciscus Anna</creatorcontrib><creatorcontrib>De Cleyn, Michel Anna Jozef</creatorcontrib><creatorcontrib>Delgado-González, Óscar</creatorcontrib><creatorcontrib>Mateu Sanchís, Natalia</creatorcontrib><creatorcontrib>Gijsen, Henricus Jacobus Maria</creatorcontrib><creatorcontrib>Fustero Lardiés, Santos</creatorcontrib><creatorcontrib>Van Gool, Michiel Luc Maria</creatorcontrib><creatorcontrib>Trabanco-Suárez, Andrés Avelino</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Van Brandt, Sven Franciscus Anna</au><au>De Cleyn, Michel Anna Jozef</au><au>Delgado-González, Óscar</au><au>Mateu Sanchís, Natalia</au><au>Gijsen, Henricus Jacobus Maria</au><au>Fustero Lardiés, Santos</au><au>Van Gool, Michiel Luc Maria</au><au>Trabanco-Suárez, Andrés Avelino</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>2,3,4,5-tetrahydropyridin-6-amine and 3,4-dihydro-2H-pyrrol-5-amine compound inhibitors of beta-secretase</title><date>2018-10-23</date><risdate>2018</risdate><abstract>wherein the radicals are as defined in the specification. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention and treatment of disorders in which beta-secretase is involved, such as Alzheimer's disease (AD), mild cognitive impairment, senility, dementia, dementia with Lewy bodies, Down's syndrome, dementia associated with stroke, dementia associated with Parkinson's disease, dementia associated with beta-amyloid, age-related macular degeneration, type 2 diabetes or metabolic disorders.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US10106524B2
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title 2,3,4,5-tetrahydropyridin-6-amine and 3,4-dihydro-2H-pyrrol-5-amine compound inhibitors of beta-secretase
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T23%3A40%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Van%20Brandt,%20Sven%20Franciscus%20Anna&rft.date=2018-10-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS10106524B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true